+Hosted content

New Zealand GPs are being urged to be aware of an early stage of Alzheimer’s disease as recent research helps to provide hope for diagnosed patients

The digital era has come a long way in helping both medical practices and solo practitioners work smarter, not harder

Following the onset of severe symptomatic aortic stenosis (SSAS), 50 per cent of patients die within one to two years of diagnosis

Head and neck carcinoma is now the sixth most common cancer worldwide¹

Mr Rajan Patel, leading head and neck surgeon at MercyAscot talks about red flag signs and symptoms that may suggest head and neck cancer

Dulaglutide, a once-weekly injectable medicine, will soon be available for second-line treatment of type 2 diabetes. As most people with type 2 diabetes will require an injectable therapy at some stage, it is important to build acceptability early in the patient journey

The effect of ENTRESTO® on physical and social activities compared with enalapril was equivalent to a difference of 9 years of ageing.¹

Diabetes clinical nurse specialist Lisa Sparks discusses the place of empagliflozin and dulaglutide in treatment of type 2 diabetes, with emphasis on potential side effects, sick-day management and improving patient adherence

All patients with heart failure with reduced ejection fraction (HFrEF), regardless of their symptoms have a poor prognosis. Within three years, 34% of patients with mild to moderate heart failure (NYHA class I and II) die¹

Introducing to our valued New Zealand Doctor Rata Aotearoa subscribers, the new Capture button